Celegato, M.; Messa, L.; Bertagnin, C.; Mercorelli, B.; Loregian, A.
Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells. Cancers 2022, 14, 193.
https://doi.org/10.3390/cancers14010193
AMA Style
Celegato M, Messa L, Bertagnin C, Mercorelli B, Loregian A.
Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells. Cancers. 2022; 14(1):193.
https://doi.org/10.3390/cancers14010193
Chicago/Turabian Style
Celegato, Marta, Lorenzo Messa, Chiara Bertagnin, Beatrice Mercorelli, and Arianna Loregian.
2022. "Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells" Cancers 14, no. 1: 193.
https://doi.org/10.3390/cancers14010193
APA Style
Celegato, M., Messa, L., Bertagnin, C., Mercorelli, B., & Loregian, A.
(2022). Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells. Cancers, 14(1), 193.
https://doi.org/10.3390/cancers14010193